(Q42664078)

English

Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan

scientific article published on August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

multicenter clinical trial

1 reference

based on heuristic

inferred from title

calcium carbonate

0 references

author name string

Fumihiko Koiwa

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Noritaka Onoda

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Hitoshi Kato

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Akihide Tokumoto

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Tomoyuki Okada

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Masashi Fukagawa

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Takashi Shigematsu

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

ROD 21 Clinical Research Group

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Therapeutic Apheresis and Dialysis

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

340-346

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Phosphate regulation of vascular smooth muscle cell calcification

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00294.X

21 January 2018

Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00294.X

21 January 2018

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00294.X

21 January 2018

Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00294.X

21 January 2018

Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00294.X

21 January 2018

A prospective study of combination therapy for hyperphosphataemia with calcium-containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00294.X

21 January 2018

Combination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral management.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00294.X

21 January 2018

Identifiers

10.1111/J.1744-9987.2005.00294.X

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42664078&oldid=1964965033"